Zumiez, Inc. (ZUMZ) Tops Q1 EPS by 1c; Guides In-Line
Tweet
Share
E-mailGet Alerts ZUMZ Hot Sheet
Price: $18.90 --0%
Revenue Growth %: +1.9%
Financial Fact:
Basic earnings (loss) per share: 0.44
Today's EPS Names:
OTLK, EGRX, MOVE, More
Revenue Growth %: +1.9%
Financial Fact:
Basic earnings (loss) per share: 0.44
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Zumiez, Inc. (NASDAQ: ZUMZ) reported Q1 EPS of $0.13, $0.01 better than the analyst estimate of $0.12. Revenue for the quarter came in at $148.5 million versus the consensus estimate of $147.26 million.
Comparable store sales for the thirteen weeks ended May 4, 2013 decreased (0.7%) compared to a comparable store sales increase of 12.9% for the thirteen weeks ended April 28, 2012.
Zumiez, Inc. sees Q2 2013 EPS of $0.16-0.18, versus the consensus of $0.17. Zumiez, Inc. sees Q2 2013 revenue of $155-158 million, versus the consensus of $156.8 million.
For earnings history and earnings-related data on Zumiez, Inc. (ZUMZ) click here.
Comparable store sales for the thirteen weeks ended May 4, 2013 decreased (0.7%) compared to a comparable store sales increase of 12.9% for the thirteen weeks ended April 28, 2012.
Zumiez, Inc. sees Q2 2013 EPS of $0.16-0.18, versus the consensus of $0.17. Zumiez, Inc. sees Q2 2013 revenue of $155-158 million, versus the consensus of $156.8 million.
For earnings history and earnings-related data on Zumiez, Inc. (ZUMZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, Guidance, Retail SalesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
